Clostridioides difficile, otherwise known as C. diff, has killed more than one in 10 cases from 2023 to 2024. Concerned doctors are warning the death toll could continue to soar if action isn't ...

BRITS have been warned as a deadly bacteria that kills one in 10 sufferers has spiked in the UK. Cases of the “worst diarrhoea ever” are rising – here are three symptoms to watch … ...

Cases of the highly infectious bacteria Clostridioides difficile, or C. diff, which has killed thousands have soared to a 12 year high.

People with ulcerative colitis are susceptible to an infection from a bacterium called Clostridioides difficile, or C. diff. Here’s what to do if you think you have it.

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin ...

Here are the C. diff infection rates of PPS-exempt cancer hospitals between July 7, 2023, and June 30, 2024, according to CMS data: University of Texas MD Anderson Cancer Center (Houston): 0.237 ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence ...

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found.

Research has found that C. difficile, one of the most common and contagious hospital-acquired infections, spreads more than three times more than previously thought, moving covertly from surface to ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in Phase 2. Data expected in 2025.